Braun MM - Search Results

1

Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents.

Slifman NR, Gershon SK, Lee JH, Edwards ET, Braun MM. Slifman NR, et al. Among authors: braun mm. Arthritis Rheum. 2003 Feb;48(2):319-24. doi: 10.1002/art.10758. Arthritis Rheum. 2003. PMID: 12571839

2

Vaccine risk perception among reporters of autism after vaccination: vaccine adverse event reporting system 1990-2001.

Woo EJ, Ball R, Bostrom A, Shadomy SV, Ball LK, Evans G, Braun M. Woo EJ, et al. Am J Public Health. 2004 Jun;94(6):990-5. doi: 10.2105/ajph.94.6.990. Am J Public Health. 2004. PMID: 15249304 Free PMC article.

3

Infections and human tissue transplants: review of FDA MedWatch reports 2001-2004.

Wang S, Zinderman C, Wise R, Braun M. Wang S, et al. Cell Tissue Bank. 2007;8(3):211-9. doi: 10.1007/s10561-007-9034-3. Epub 2007 Feb 3. Cell Tissue Bank. 2007. PMID: 17278013

4

Monitoring the safety of vaccines: assessing the risks.

Ellenberg SS, Braun MM. Ellenberg SS, et al. Among authors: braun mm. Drug Saf. 2002;25(3):145-52. doi: 10.2165/00002018-200225030-00001. Drug Saf. 2002. PMID: 11945111

5

Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.

McMahon AW, Eidex RB, Marfin AA, Russell M, Sejvar JJ, Markoff L, Hayes EB, Chen RT, Ball R, Braun MM, Cetron M; Yellow Fever Working Group. McMahon AW, et al. Among authors: braun mm. Vaccine. 2007 Feb 26;25(10):1727-34. doi: 10.1016/j.vaccine.2006.11.027. Epub 2006 Nov 27. Vaccine. 2007. PMID: 17240001

6

Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005.

Dobardzic A, Izurieta H, Woo EJ, Iskander J, Shadomy S, Rupprecht C, Ball R, Braun MM. Dobardzic A, et al. Among authors: braun mm. Vaccine. 2007 May 22;25(21):4244-51. doi: 10.1016/j.vaccine.2007.02.075. Epub 2007 Mar 15. Vaccine. 2007. PMID: 17382435 Clinical Trial.

7

Documented tuberculin skin testing among infliximab users following a multi-modal risk communication interventions.

Shatin D, Rawson NS, Curtis JR, Braun MM, Martin CK, Moreland LW, Becker AF, Patkar NM, Allison JJ, Saag KG. Shatin D, et al. Among authors: braun mm. Pharmacoepidemiol Drug Saf. 2006 Jan;15(1):11-8. doi: 10.1002/pds.1132. Pharmacoepidemiol Drug Saf. 2006. PMID: 16136625

8

Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents.

Mohan N, Edwards ET, Cupps TR, Slifman N, Lee JH, Siegel JN, Braun MM. Mohan N, et al. Among authors: braun mm. J Rheumatol. 2004 Oct;31(10):1955-8. J Rheumatol. 2004. PMID: 15468359

9

Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.

O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. O'Connell KA, et al. Among authors: braun mm. JAMA. 2006 Jan 18;295(3):293-8. doi: 10.1001/jama.295.3.293. JAMA. 2006. PMID: 16418464

10

Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the vaccine: Adverse Event Reporting System.

Ball R, Halsey N, Braun MM, Moulton LH, Gale AD, Rammohan K, Wiznitzer M, Johnson R, Salive ME; VAERS Working Group. Ball R, et al. Among authors: braun mm. J Clin Epidemiol. 2002 Aug;55(8):819-24. doi: 10.1016/s0895-4356(01)00500-5. J Clin Epidemiol. 2002. PMID: 12384197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results